Envoy Medical, Inc. COCH
Set alert
6.85 USD +0.22 +3.32%
As of Nov 2, 12:31 PM ET
6.60 Day range 7.09
3.63 52-week range 9.54
- YTD
- +3.63%
- 1 year
- -14.91%
- Open
- 6.68
- Prev close
- 6.63
- Mkt cap
- 51.47M
- Vol
- 3.42K
- Avg vol
- 12.51K
- EPS
- -7.60
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 6.60
- High
- 7.09
- Forward P/E
- -1.43
- Beta
- 2.36
- Short ratio
- 1.75
- Inst. own
- 6.08%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 12, 2024
- 50-d avg
- 2.25
- 200-d avg
- 3.10
- 1y target
- 6.50
Financial health
Altman Z-Score
-20.16 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C-1 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 2
- P/E 1
- P/B 1
Valuation
P/E -0.5×
FY 2020 5y median -1.0× FY 2025
P/S 63.8×
FY 2020 5y median 119× FY 2025
P/B -1.3×
FY 2020 5y median -2.2× FY 2025
P/FCF -0.8×
FY 2020 5y median -1.4× FY 2025
EV/EBITDA -0.6×
FY 2020 5y median -2.1× FY 2025
EV/Sales 52.1×
FY 2020 5y median 182× FY 2025
FCF Yield -119.5%
FY 2020 5y median -70.4% FY 2025
Profitability
Gross Margin -262.7%
FY 2020 5y median -149.7% FY 2025
Operating Margin -9240.7%
FY 2020 5y median -5809.8% FY 2025
Net Margin -9857.3%
FY 2020 5y median -9242.2% FY 2025
ROE 201.9%
FY 2020 5y median 110.4% FY 2025
ROIC 786.9%
FY 2020 5y median -554.1% FY 2025
ROA -277.6%
FY 2020 5y median -330.6% FY 2025
Growth (YoY)
Revenue 7.1%
FY 2020 FY 2025
Operating Income -15.7%
FY 2020 FY 2025
EPS (diluted) 17.4%
FY 2020 FY 2025
Free Cash Flow 2.9%
FY 2020 FY 2025
Financial Health
Current Ratio 0.5×
FY 2020 5y median 1.0× FY 2025
Quick Ratio 0.4×
FY 2020 5y median 0.8× FY 2025
Debt / Equity -0.1×
FY 2020 5y median -0.5× FY 2025
Net Debt / EBITDA 0.1×
FY 2020 5y median -0.7× FY 2025
Interest Coverage -14.0×
FY 2020 5y median 0.0× FY 2025
Dividends
Dividend Yield 11.8%
FY 2020 5y median 0.0% FY 2025
Payout Ratio -7.7%
FY 2020 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31